Payments to Acquire Property, Plant, and Equipment of Corvus Pharmaceuticals, Inc. from 31 Mar 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Corvus Pharmaceuticals, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2015 to 31 Dec 2025.
  • Corvus Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $36,000.
  • Corvus Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $174,000.
  • Corvus Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $34,000, a 87% decline from 2022.
  • Corvus Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $269,000, a 5280% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Corvus Pharmaceuticals, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $174,000 01 Jan 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
2023 $34,000 -$235,000 -87% 01 Jan 2023 31 Dec 2023 10-K 12 Mar 2026 2025 FY
2022 $269,000 +$264,000 +5280% 01 Jan 2022 31 Dec 2022 10-K 25 Mar 2025 2024 FY
2021 $5,000 -$71,000 -93% 01 Jan 2021 31 Dec 2021 10-K 19 Mar 2024 2023 FY
2020 $76,000 +$51,000 +204% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2023 2021 FY
2019 $25,000 -$330,000 -93% 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2022 2021 FY
2018 $355,000 +$89,000 +33% 01 Jan 2018 31 Dec 2018 10-K 25 Mar 2021 2020 FY
2017 $266,000 -$1,933,000 -88% 01 Jan 2017 31 Dec 2017 10-K 09 Mar 2020 2019 FY
2016 $2,199,000 +$452,000 +26% 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2019 2018 FY
2015 $1,747,000 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY

Corvus Pharmaceuticals, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $36,000 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2023 $34,000 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2019 $16,000 +$10,000 +167% 01 Jan 2019 31 Mar 2019 10-Q 30 Apr 2020 2020 Q1
Q1 2018 $6,000 -$105,000 -95% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $111,000 -$503,000 -82% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q1 2016 $614,000 +$290,000 +90% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017 2017 Q1
Q1 2015 $324,000 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.